Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov;125(2):280-285.
doi: 10.1016/j.radonc.2017.09.009. Epub 2017 Oct 4.

Treating locally advanced lung cancer with a 1.5T MR-Linac - Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy

Affiliations

Treating locally advanced lung cancer with a 1.5T MR-Linac - Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy

Hannah E Bainbridge et al. Radiother Oncol. 2017 Nov.

Abstract

Purpose: This study investigates the feasibility and potential benefits of radiotherapy with a 1.5T MR-Linac for locally advanced non-small cell lung cancer (LA NSCLC) patients.

Material and methods: Ten patients with LA NSCLC were retrospectively re-planned six times: three treatment plans were created according to a protocol for conventionally fractionated radiotherapy and three treatment plans following guidelines for isotoxic target dose escalation. In each case, two plans were designed for the MR-Linac, either with standard (∼7mm) or reduced (∼3mm) planning target volume (PTV) margins, while one conventional linac plan was created with standard margins. Treatment plan quality was evaluated using dose-volume metrics or by quantifying dose escalation potential.

Results: All generated treatment plans fulfilled their respective planning constraints. For conventionally fractionated treatments, MR-Linac plans with standard margins had slightly increased skin dose when compared to conventional linac plans. Using reduced margins alleviated this issue and decreased exposure of several other organs-at-risk (OAR). Reduced margins also enabled increased isotoxic target dose escalation.

Conclusion: It is feasible to generate treatment plans for LA NSCLC patients on a 1.5T MR-Linac. Margin reduction, facilitated by an envisioned MRI-guided workflow, enables increased OAR sparing and isotoxic target dose escalation for the respective treatment approaches.

Keywords: Dose-escalation; Lung cancer; MR-Linac; MRI-guided radiotherapy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Differences in the investigated dose–volume metrics between the plans designed for the MR-Linac with either standard or reduced margins and the conventional linac. Numerically positive differences mark an increase in the respective metric for the MR-Linac plans. Displayed are the first and third quartiles (boxes), medians (bands inside), average values (crosses), standard deviations (whiskers) and outliers (circles).
Fig. 2
Fig. 2
Dose distribution of the conventionally fractionated treatment plans for patient 1 displayed over an axial (left), coronal (central) and sagittal (right) slice of the average phase of the 4DCT scan. Plans were created either for a conventional linac with standard margins (top row) or the MR-Linac with reduced margins (bottom row). Marked are the ITV (red) as well as the 95% (blue), 50% (yellow) isodose contours.

References

    1. Aupérin A., Le Péchoux C., Rolland E. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non - small-cell lung cancer. J Clin Oncol. 2010;28:2181–2190. - PubMed
    1. Machtay M., Paulus R., Moughan J. Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma. J Thorac Oncol. 2012;7:716–722. - PMC - PubMed
    1. Christodoulou M., Bayman N., McCloskey P., Rowbottom C., Faivre-Finn C. New radiotherapy approaches in locally advanced non-small cell lung cancer. Eur J Cancer. 2014;50:525–534. - PubMed
    1. Onishi H., Shirato H., Nagata Y. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thoracic Oncol. 2007;2:S94–S100. - PubMed
    1. Faivre-Finn C. Dose escalation in lung cancer: have we gone full circle? Lancet Oncol. 2015;16:125–127. - PubMed

MeSH terms